Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Bivalent gambogic acid-functionalized curcumin nanoparticles with insulin modulate the gut-liver-kidney network in type 2 diabetes.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 25, 2026
Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies.
Journal: Pharmacological reviews
Published: February 28, 2024
Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38/P53 signaling axis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 02, 2022
Oral Nanocurcumin Alone or in Combination with Insulin Alleviates STZ-Induced Diabetic Neuropathy in Rats.
Journal: Molecular pharmaceutics
Published: September 15, 2022
Systematic Review of Community Paramedicine and EMS Mobile Integrated Health Care Interventions in the United States.
Journal: Population health management
Published: January 08, 2019
Showing 1-6 of 6
Last Updated: 09/26/2026